ID: ALA1214872

Max Phase: Preclinical

Molecular Formula: C40H52N7Na2O18P

Molecular Weight: 951.88

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@]2(O)c1cn(CC(=O)N[C@H]2[C@H]([C@H](O)[C@H](O)CO)O[C@](OP(=O)([O-])OC[C@H]3O[C@@H](n4ccc(N)nc4=O)[C@H](O)[C@@H]3O)(C(=O)[O-])C[C@@H]2O)nn1.[Na+].[Na+]

Standard InChI:  InChI=1S/C40H54N7O18P.2Na/c1-38-9-6-21-20-5-3-19(49)12-18(20)2-4-22(21)23(38)7-10-39(38,59)27-14-46(45-44-27)15-29(52)43-30-24(50)13-40(36(56)57,64-34(30)31(53)25(51)16-48)65-66(60,61)62-17-26-32(54)33(55)35(63-26)47-11-8-28(41)42-37(47)58;;/h3,5,8,11-12,14,21-26,30-35,48-51,53-55,59H,2,4,6-7,9-10,13,15-17H2,1H3,(H,43,52)(H,56,57)(H,60,61)(H2,41,42,58);;/q;2*+1/p-2/t21-,22-,23+,24+,25-,26-,30-,31-,32-,33-,34-,35-,38+,39-,40-;;/m1../s1

Standard InChI Key:  BZGJOPIGYGFDSV-IBUAGRFKSA-L

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase 29 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 951.88Molecular Weight (Monoisotopic): 951.3263AlogP: -2.55#Rotatable Bonds: 14
Polar Surface Area: 394.08Molecular Species: ACIDHBA: 22HBD: 12
#RO5 Violations: 3HBA (Lipinski): 25HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.47CX Basic pKa: 1.50CX LogP: -2.06CX LogD: -7.93
Aromatic Rings: 3Heavy Atoms: 66QED Weighted: 0.07Np Likeness Score: 1.19

References

1. Hosoguchi K, Maeda T, Furukawa J, Shinohara Y, Hinou H, Sekiguchi M, Togame H, Takemoto H, Kondo H, Nishimura S..  (2010)  An efficient approach to the discovery of potent inhibitors against glycosyltransferases.,  53  (15): [PMID:20684602] [10.1021/jm100612r]

Source